Seminiferous Tubules‐Targeted Resveratrol Carbon Dots With Sertoli Cell Biomimetic Vesicles Fusion for Improving Spermatogenesis of Cryptorchidism
Advanced Healthcare Materials · 2026
DOI: 10.1002/adhm.71671 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Chaoying Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Huanghuai University, Zhumadian, China. Hauptthemen laut MEDLINE: Sertoli Cells, Resveratrol, Spermatogenesis, Cryptorchidism. Die Arbeit nennt 64 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Henan Province, Zhumadian Key R&D Special Project.
Abstract (Originalsprache)
Impaired blood‐testis barrier (BTB) integrity, induced by oxidative stress, is one of the primary factors leading to spermatogenic disorders in cryptorchidism. Therefore, the targeted elimination of testicular oxidative stress and repair of the BTB are promising strategies for promoting spermatogenesis in patients with cryptorchidism. This study aimed to demonstrate the potential of Sertoli cell membrane‐camouflaged biomimetic vesicles loaded with resveratrol carbon dots (RCD@PCy@EVs) as a therapeutic nanoagent for cryptorchidism treatment in vivo. The prepared RCD@PCy@EVs are actively targeted to the seminiferous tubules by leveraging the homing tendency of the Sertoli cell membrane, guided by fluorescence imaging. The RCD@PCy@EVs not only reshape the redox microenvironment of the seminiferous tubules and alleviate inflammatory responses by scavenging reactive oxygen species, but they also increase the expression of the tight junction protein β‐catenin and restore BTB integrity, which is associated with the activation of the SIRT1/AMPKα/FOXO1 signaling pathway. More importantly, functional spermatogenesis is markedly improved by RCD@PCy@EVs, effectively restoring reproductive function in cryptorchid mice. The RCD@PCy@EVs‐mediated therapy for cryptorchidism offers a novel strategy for treating male infertility.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine, Huanghuai University, Zhumadian, China.
- China Pharmaceutical Valley (Zhumadian) Research Institute, Huanghuai University, Zhumadian, China.
- Institute for Engineering Medicine, Kunming Medical University, Kunming, China.
- School of Inspection, Ningxia Medical University, Yinchuan, Ningxia, China.
- Department of Orthopedics, The First Affiliated Hospital of Jinan University, Guangzhou, China.
- College of Biology and Food Engineering, Huanghuai University, Zhumadian, China.
ORCID-Profile: Zhisheng Ji, Judun Zheng, Yuhui Liao, Enzhong Li
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Henan Province
- Zhumadian Key R&D Special Project
- Key Research Projects of Higher Education Institutions in Henan Province
- National Key Research and Development Program of China
- Natural Science Fund of Guangdong Province for Distinguished Young Scholars
- Basic and Applied Basic Research Project of Guangzhou
- Key Research Projects of Ningxia Medical University
Zitieren
APA
Liu, C., Li, X., Li, B., Yang, H., Wang, Y., Ji, Z., Zheng, J., Liao, Y., & Li, E. (2026). Seminiferous Tubules‐Targeted Resveratrol Carbon Dots With Sertoli Cell Biomimetic Vesicles Fusion for Improving Spermatogenesis of Cryptorchidism. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.71671
Vancouver
Liu C, Li X, Li B, Yang H, Wang Y, Ji Z, et al. Seminiferous Tubules‐Targeted Resveratrol Carbon Dots With Sertoli Cell Biomimetic Vesicles Fusion for Improving Spermatogenesis of Cryptorchidism. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.71671
BibTeX
@article{Liu2026,
author = {Liu, Chaoying and Li, Xipeng and Li, Bin and Yang, Hua and Wang, Ye and Ji, Zhisheng and Zheng, Judun and Liao, Yuhui and Li, Enzhong},
title = {Seminiferous Tubules‐Targeted Resveratrol Carbon Dots With Sertoli Cell Biomimetic Vesicles Fusion for Improving Spermatogenesis of Cryptorchidism},
journal = {Advanced Healthcare Materials},
year = {2026},
doi = {10.1002/adhm.71671}
}
EUVIMED